WO2003000191A3 - Composition comprising glycosaminogycans and hyaluronidase inhibitors for the treatment of arthritic joints - Google Patents
Composition comprising glycosaminogycans and hyaluronidase inhibitors for the treatment of arthritic joints Download PDFInfo
- Publication number
- WO2003000191A3 WO2003000191A3 PCT/US2002/019718 US0219718W WO03000191A3 WO 2003000191 A3 WO2003000191 A3 WO 2003000191A3 US 0219718 W US0219718 W US 0219718W WO 03000191 A3 WO03000191 A3 WO 03000191A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hyaluronic acid
- composition
- hyaluronidase inhibitor
- preferred
- hyaluronidase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002451248A CA2451248A1 (en) | 2001-06-25 | 2002-06-20 | Composition comprising glycosaminoglycans and hyaluronidase inhibitors for the treatment of arthritic joints |
JP2003506637A JP2005521629A (en) | 2001-06-25 | 2002-06-20 | Composition comprising glycosaminoglycan and hyaluronidase inhibitor for treating arthritic joints |
EP02739947A EP1423081A4 (en) | 2001-06-25 | 2002-06-20 | Composition comprising glycosaminogycans and hyaluronidase inhibitors for the treatment of arthritic joints |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30073401P | 2001-06-25 | 2001-06-25 | |
US60/300,734 | 2001-06-25 | ||
US74102A | 2002-06-06 | 2002-06-06 | |
USDEP-741 | 2002-06-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003000191A2 WO2003000191A2 (en) | 2003-01-03 |
WO2003000191A3 true WO2003000191A3 (en) | 2004-03-11 |
Family
ID=26668090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/019718 WO2003000191A2 (en) | 2001-06-25 | 2002-06-20 | Composition comprising glycosaminogycans and hyaluronidase inhibitors for the treatment of arthritic joints |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1423081A4 (en) |
JP (1) | JP2005521629A (en) |
CA (1) | CA2451248A1 (en) |
WO (1) | WO2003000191A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109758607A (en) * | 2019-03-08 | 2019-05-17 | 宁夏妙朗生物科技有限公司 | Resist the cross-linked hyaluronic acid gel of hyaluronic acid enzyme hydrolysis |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4703948B2 (en) * | 2003-05-20 | 2011-06-15 | 丸善製薬株式会社 | Anti-allergic agent, anti-aging agent and anti-aging skin external preparation |
AU2005272578A1 (en) * | 2004-08-13 | 2006-02-23 | Angiotech International Ag | Compositions and methods using hyaluronic acid and hyluronidase inhibitors |
AU2013270451B2 (en) * | 2005-10-03 | 2016-05-12 | Mark A. Pinsky | Compositions and methods for improved skin care |
EP2019647A4 (en) * | 2006-05-19 | 2010-04-28 | Univ Boston | Novel hydrophilic polymers as medical lubricants and gels |
WO2008139123A2 (en) * | 2007-05-11 | 2008-11-20 | Galderma Research & Development | Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same |
WO2008139122A2 (en) * | 2007-05-11 | 2008-11-20 | Galderma Research & Development | Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same |
US8394782B2 (en) | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
ITMI20072348A1 (en) | 2007-12-17 | 2009-06-18 | Medichem Srl | METHOD FOR CELL RIGENERATION OF HYALURONIC ACID AND ITS COSMETIC COMPOSITION |
MX2010012326A (en) * | 2008-05-19 | 2010-12-01 | Univ North Carolina | Methods and compositions comprising novel cationic lipids. |
ITMI20090779A1 (en) * | 2009-05-08 | 2010-11-08 | Vitrupharm Srl | NUTRITIONAL COMPOSITIONS BASED ON CISTEIN RESVERATROL OR ITS DERIVATIVES OR METABOLITES AND ASTAXANTIN |
US9913810B2 (en) | 2009-07-23 | 2018-03-13 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using phospholipids and astaxanthin |
US8557275B2 (en) | 2009-07-23 | 2013-10-15 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA |
US9399047B2 (en) | 2009-07-23 | 2016-07-26 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using phospholipids and roe extract |
US8481072B2 (en) | 2009-07-23 | 2013-07-09 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain |
US9402857B2 (en) | 2009-07-23 | 2016-08-02 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin |
US9238043B2 (en) | 2009-07-23 | 2016-01-19 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using algae based oils |
US9216164B2 (en) | 2009-07-23 | 2015-12-22 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA |
US8637569B2 (en) | 2009-10-22 | 2014-01-28 | Api Genesis, Llc | Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds |
EP2490679B8 (en) | 2009-10-22 | 2022-10-26 | Tpc-Api Llc | Methods of making and using compositions comprising flavonoids |
WO2011160146A1 (en) * | 2010-06-23 | 2011-12-29 | Croma-Pharma Gesellschaft M.B.H. | Pharmaceutical preparation containing dextran and sodium hyaluronate for the treatment of joint disorders |
US8716204B2 (en) | 2010-07-27 | 2014-05-06 | Zimmer, Inc. | Synthetic synovial fluid compositions and methods for making the same |
ITRM20100614A1 (en) * | 2010-11-24 | 2012-05-25 | D M G Italia S R L | PHARMACEUTICAL PREPARATIONS OF ACID 18 GLYCYRRHETIC BETA AND / OR OF ITS DERIVATIVES FOR INTRARTICULAR INFILTRATIONS FOR THE TREATMENT OF INFLAMMATORY ARTROPATHIES |
FR2991876B1 (en) * | 2012-06-13 | 2014-11-21 | Vivacy Lab | COMPOSITION, IN AQUEOUS MEDIUM, COMPRISING AT LEAST ONE HYALURONIC ACID AND AT LEAST ONE WATER-SOLUBLE SALT OF SUCROSE OCTASULFATE |
US20190000874A1 (en) * | 2015-08-13 | 2019-01-03 | Newven Sprl | Composition for the Treatment of Joint Conditions |
DE102016208567A1 (en) * | 2016-05-19 | 2017-11-23 | Heraeus Medical Gmbh | Polymer solution for viscous supplementation |
MX2020002041A (en) | 2017-08-22 | 2020-08-13 | Moebius Medical Ltd | Liposomal formulation for joint lubrication. |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4239754A (en) * | 1976-10-23 | 1980-12-16 | Choay, S.A. | Liposomes containing heparin and a process for obtaining them |
US4743596A (en) * | 1987-06-16 | 1988-05-10 | Lapin Alfred R | Anti-arthritic preparation |
US6136795A (en) * | 1998-11-18 | 2000-10-24 | Omni Nutraceuticals, Inc | Dietary regimen of nutritional supplements for relief of symptoms of arthritis |
US6232315B1 (en) * | 1998-09-28 | 2001-05-15 | Merck & Co., Inc. | Method for treating inflammatory diseases by administering a thrombin inhibitor |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK191889D0 (en) * | 1989-04-20 | 1989-04-20 | Bukh Meditec | COSMETIC AGENT |
JP2003501381A (en) * | 1999-06-07 | 2003-01-14 | ユニバーシティ・オブ・シェフィールド | Arthritis treatment |
-
2002
- 2002-06-20 EP EP02739947A patent/EP1423081A4/en not_active Withdrawn
- 2002-06-20 CA CA002451248A patent/CA2451248A1/en not_active Abandoned
- 2002-06-20 JP JP2003506637A patent/JP2005521629A/en not_active Withdrawn
- 2002-06-20 WO PCT/US2002/019718 patent/WO2003000191A2/en active Search and Examination
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4239754A (en) * | 1976-10-23 | 1980-12-16 | Choay, S.A. | Liposomes containing heparin and a process for obtaining them |
US4743596A (en) * | 1987-06-16 | 1988-05-10 | Lapin Alfred R | Anti-arthritic preparation |
US6232315B1 (en) * | 1998-09-28 | 2001-05-15 | Merck & Co., Inc. | Method for treating inflammatory diseases by administering a thrombin inhibitor |
US6136795A (en) * | 1998-11-18 | 2000-10-24 | Omni Nutraceuticals, Inc | Dietary regimen of nutritional supplements for relief of symptoms of arthritis |
Non-Patent Citations (1)
Title |
---|
See also references of EP1423081A4 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109758607A (en) * | 2019-03-08 | 2019-05-17 | 宁夏妙朗生物科技有限公司 | Resist the cross-linked hyaluronic acid gel of hyaluronic acid enzyme hydrolysis |
CN109758607B (en) * | 2019-03-08 | 2021-07-27 | 宁夏妙朗生物科技有限公司 | Cross-linked hyaluronic acid gels resistant to hydrolysis by hyaluronidase |
Also Published As
Publication number | Publication date |
---|---|
CA2451248A1 (en) | 2003-01-03 |
JP2005521629A (en) | 2005-07-21 |
WO2003000191A2 (en) | 2003-01-03 |
EP1423081A4 (en) | 2005-05-25 |
EP1423081A2 (en) | 2004-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003000191A3 (en) | Composition comprising glycosaminogycans and hyaluronidase inhibitors for the treatment of arthritic joints | |
CA2390824A1 (en) | Stabilized aqueous acidic antiperspirant compositions and related methods | |
WO2003063799A3 (en) | Compositions and methods for systemic inhibition of cartilage degradation | |
WO2003079972A3 (en) | Active agent delivery systems and methods for protecting and administering active agents | |
HK1114774A1 (en) | Compositions comprising an aminosugar, chondroitin, and s- adenosylmethionine | |
WO2001015678A3 (en) | Topical use of kappa opioid agonists to treat otic pain | |
CA2461941A1 (en) | Anti-irritating rosacea treatment | |
WO2003045344A3 (en) | Dentifrice compositions | |
ES2170256T3 (en) | COMPOSITIONS FOR THE TOPICAL SUPPLY OF ACTIVE INGREDIENTS. | |
WO2003053336A3 (en) | Methods for the treatment of peripheral neural and vascular ailments | |
MY130477A (en) | Pharmaceutical compositions for the treatmen of mucositis, stomatitis and behcet,s syndrome | |
CA2371372A1 (en) | Copper/amine oxide wood preservatives | |
WO2006118980A3 (en) | Long-chain quaternary ammonium compounds as wood treatment agents | |
WO2005030753A3 (en) | Therapeutic agents useful for treating pain | |
PL336482A1 (en) | Application of zinc hyaluronate against a peptic ulcer | |
AR018357A1 (en) | PETROSELINIC ACID IN A COMPOSITION AND IN A METHOD TO REDUCE OR ELIMINATE THE IRRITATION OR THE PICAZON OF THE SKIN INDUCED BY ALFA-HYDROXIACIDES | |
WO1997044007A3 (en) | A barrier cream comprising hexamethylenetetramine or derivative thereof | |
CA2334257A1 (en) | Treatment of osteoporosis with ep2/ep4 receptor selective agonists | |
CA2343439A1 (en) | Compositions useful in the treatment of diseases of connective tissues | |
AU2101800A (en) | Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis | |
CA2275167A1 (en) | The topical use of kappa opioid agonists to treat ocular pain | |
BR0317456A (en) | Condom enhancements for wood-based products | |
WO2003032925A3 (en) | Glycosulfopeptide inhibitors and methods of use thereof | |
WO2002060381A3 (en) | Cholesterol sulfate and amino sugar compositions for enhancement of stratum corneum function | |
EP1155677A3 (en) | Methods and compositions for inhibiting free radical polymerization in skin and hair |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003506637 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2451248 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002312564 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002739947 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2002739947 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002739947 Country of ref document: EP |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) |